Last updated: 2026-10-13 13:47:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Microbot Medical, Inc. (MBOT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.04, with a market capitalisation of $71.87M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.03 to $3.04. This page covers its latest market performance, valuation, price trends and company information.
$71.87M | |
$1.03 | |
$192.03 | |
$0.82 | |
$1.04 | |
40.51K | |
657.73K | |
-- | |
$3.04 | |
$1.03 | |
-- | |
-- |
Microbot Medical, Inc. (MBOT) is currently trading at $1.04 as of 2026-10-13 13:45:00, down 0.48% ($0.01) from the previous close of $1.04
During today's regular trading session, MBOT has traded between $0.82 and $192.03, with a trading volume of 40.51K shares. The current price is near the lower end of today's range.
Over the past seven days, Microbot Medical, Inc. (MBOT) moved from $1.16 to $1.04, representing a decline of 10.78% ($0.13).
The stock traded between $1.03 and $1.23 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.00 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.2%
MBOT is currently trading at $1.04, placing it 0.2% of the way from its 52-week low of $1.03 to its 52-week high of $3.04. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 22 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Microbot Medical, Inc. (MBOT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.